Treatment of Undifferentiated Embryonal Sarcoma of the Liver in Children

Author:

Lin Wen-Ya1,Wu Kang-Hsi23ORCID,Chen Chun-Yu45,Guo Bei-Cyuan6ORCID,Chang Yu-Jun7ORCID,Lin Mao-Jen89,Wu Han-Ping1011ORCID

Affiliation:

1. Department of Pediatrics, Taichung Veterans General Hospital, Taichung 407219, Taiwan

2. Department of Pediatrics, Chung Shan Medical University Hospital, Taichung 408, Taiwan

3. School of Medicine, Chung Shan Medical University, Taichung 408, Taiwan

4. Department of Emergency Medicine, Tungs’ Taichung Metro Harbor Hospital, Taichung 43503, Taiwan

5. Department of Nursing, Jen-Teh Junior College of Medicine, Nursing and Management, Miaoli 356006, Taiwan

6. Department of Pediatrics, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 70142, Taiwan

7. Laboratory of Epidemiology and Biostastics, Changhua Christian Hospital, Changhua 500, Taiwan

8. Division of Cardiology, Department of Medicine, Taichung Tzu Chi Hospital, The Buddhist Tzu Chi Medical Foundation, Taichung 427213, Taiwan

9. Department of Medicine, College of Medicine, Tzu Chi University, Hualien 97004, Taiwan

10. College of Medicine, Chang Gung University, Taoyuan 333, Taiwan

11. Department of Pediatrics, Chiayi Chang Gung Memorial Hospital, Chiayi 613, Taiwan

Abstract

Undifferentiated embryonal sarcoma of the liver is a rare mesenchymal tumor with a highly malignant potential. It occurs almost exclusively in the pediatric population and typically has a poor outcome. Although previous studies have reported dismal prognoses, recent advances in combined treatment modalities, e.g., surgery and chemotherapy, have given cause for optimism. Even in those diseases not amenable to complete surgical resection or refractory diseases, other treatment modalities, such as liver transplant, have yielded promising results. This paper provides a review of the current treatment modalities for hepatic undifferentiated embryonal sarcoma in children.

Publisher

MDPI AG

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3